AI blood test may help doctors decide who needs chemo before colon cancer surgery
NCT ID NCT07255729
First seen Jan 04, 2026 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This study aims to improve how doctors determine the stage of colon cancer before surgery and decide who should receive chemotherapy beforehand. Researchers are analyzing blood samples from 400 colon cancer patients to find specific molecules (exosomal microRNAs) that can be combined with machine learning to predict tumor aggressiveness. The goal is to create a more accurate tool than current methods, helping tailor treatment to each patient's risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.